Business Context and Reporting Period
Company: Accendra Health, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 9, 2026
Event: Entry into a Material Definitive Agreement (Section 382 Rights Agreement) and amendments to Articles of Incorporation.
The Company adopted a Tax Asset Preservation Plan to protect its Net Operating Losses (NOLs) and other tax attributes from being limited by an "ownership change" under Section 382 of the Internal Revenue Code.
Key Financial Metrics
This filing is a current report regarding a corporate governance action and does not contain financial performance data.
- Revenue, Profit, Cash Flow, Margins: Not provided in this filing.
- Debt and Liquidity: Not provided in this filing.
- Dividend Declaration: One preferred share purchase right ("Right") per outstanding Common Share.
- Right Exercise Price: $15.00 per one one-thousandth of a Series C Cumulative Preferred Share.
- Redemption Price: $0.001 per Right.
Material Changes
The primary material change is the implementation of a poison pill mechanism designed to deter hostile takeovers that could trigger a Section 382 ownership change.
- Trigger Threshold: The plan is triggered if any Person or group acquires Beneficial Ownership of 4.9% or more of the outstanding Common Shares.
- Record Date: August 20, 2026.
- Expiration: The Rights expire on the earlier of the date the Board determines they are no longer necessary or August 10, 2029.
- Corporate Structure: The Board approved Articles of Amendment designating Series C Cumulative Preferred Stock to facilitate the Rights plan.
Guidance, Outlook, and Risks
Management Commentary: The Board states the plan is intended to preserve NOLs to offset potential future taxable income. The plan is designed to reduce the likelihood of an ownership change by deterring acquisitions of 4.9% or more of the stock.
Risks and Contingencies:
- Flip-in Event: If an Acquiring Person is identified, Rights become exercisable for Common Shares with a value equal to two times the exercise price, effectively diluting the acquirer.
- Voiding of Rights: Rights held by an Acquiring Person or its affiliates become void upon the announcement of their status as an Acquiring Person.
- Redemption: The Board may redeem the Rights at $0.001 per Right at any time prior to the tenth day following a Stock Acquisition Date or the Final Expiration Date.
- Exemptions: The Board retains sole discretion to exempt specific persons or transactions from the plan.
Investor Verification Checklist
- Verify the exact number of Common Shares outstanding as of the August 20, 2026 Record Date to calculate total Rights issued.
- Review the full text of the Section 382 Rights Agreement (Exhibit 4.1) for specific definitions of "Acquiring Person" and "Beneficial Ownership."
- Confirm the current status of the Company's NOLs and the estimated value of tax attributes being protected.
- Monitor for any Board announcements regarding the redemption of Rights or the determination that the plan is no longer necessary.
- Check for any existing shareholders who may qualify as "Grandfathered Shareholders" and the conditions under which they could lose that status.